Opal Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$280K Buy
9,957
+986
+11% +$26.3K 0.06% 157
2025
Q4
$223K Hold
8,971
0.06% 187
2025
Q3
$229K Sell
8,971
-673
-7% -$16.6K 0.06% 174
2025
Q2
$234K Sell
9,644
-144
-1% -$3.36K 0.06% 176
2025
Q1
$248K Sell
9,788
-273
-3% -$7.14K 0.08% 148
2024
Q4
$267K Buy
10,061
+1,072
+12% +$29.1K 0.08% 142
2024
Q3
$260K Buy
8,989
+29
+0.3% +$846 0.08% 147
2024
Q2
$251K Sell
8,960
-260
-3% -$7.16K 0.08% 140
2024
Q1
$256K Sell
9,220
-2,439
-21% -$67.7K 0.09% 142
2023
Q4
$336K Sell
11,659
-3,214
-22% -$97.2K 0.13% 116
2023
Q3
$493K Sell
14,873
-570
-4% -$20.2K 0.29% 57
2023
Q2
$566K Buy
15,443
+5,553
+56% +$216K 0.28% 45
2023
Q1
$404K Buy
9,890
+278
+3% +$12K 0.24% 51
2022
Q4
$493K Sell
9,612
-154
-2% -$7.38K 0.27% 54
2022
Q3
$427K Buy
9,766
+55
+0.6% +$2.67K 0.31% 48
2022
Q2
$509K Buy
9,711
+1,220
+14% +$62.2K 0.34% 40
2022
Q1
$440K Buy
8,491
+145
+2% +$7.52K 0.38% 37
2021
Q4
$493K Buy
8,346
+1,463
+21% +$72.5K 0.31% 55
2021
Q3
$296K Sell
6,883
-1,408
-17% -$62.4K 0.28% 50
2021
Q2
$325K Buy
8,291
+460
+6% +$17.9K 0.3% 46
2021
Q1
$284K Buy
7,831
+2,200
+39% +$78.1K 0.31% 48
2020
Q4
$207K Buy
+5,631
New +$207K 0.26% 68

Other funds holding PFE

Opal Wealth Advisors's PFE Position: Q1 2026 in Review

Opal Wealth Advisors increased its Pfizer (PFE) stake by 11% in Q1 2026, buying an estimated $26.3K and bringing the position to 9,957 shares worth $280K. The position accounts for 0.06% of the portfolio, ranked #157.

Opal Wealth Advisors first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $566K in Q2 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Opal Wealth Advisors held 9,957 shares of Pfizer worth $280K as of Q1 2026.
  • Opal Wealth Advisors bought 986 Pfizer shares in Q1 2026, an estimated $26.3K.
  • Pfizer made up 0.06% of Opal Wealth Advisors's portfolio in Q1 2026, its #157 holding.
  • Opal Wealth Advisors first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Opal Wealth Advisors's Pfizer position peaked at $566K in Q2 2023.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Opal Wealth Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.